Kadima Institute Sues NRx Pharmaceuticals Over Alleged Acquisition Contract Breach

Kadima Neuropsychiatry Institute and its founder have filed a lawsuit against NRx Pharmaceuticals, alleging breach of contract and misrepresentation. The complaint claims NRx misrepresented its financial capacity to close an acquisition deal. Kadima is seeking specific performance to compel the completion of the transaction.